PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
ConditionSmall Cell Lung Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Essen
There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF
Histopathologic confirmation
Limited disease
Other histology than small cell lung cancer
Further tumor diagnosis
ECOG 3 or worse
Extensive disease